SE384853B - Forfarande for framstellning av nya aminer - Google Patents
Forfarande for framstellning av nya aminerInfo
- Publication number
- SE384853B SE384853B SE7204321A SE432172A SE384853B SE 384853 B SE384853 B SE 384853B SE 7204321 A SE7204321 A SE 7204321A SE 432172 A SE432172 A SE 432172A SE 384853 B SE384853 B SE 384853B
- Authority
- SE
- Sweden
- Prior art keywords
- procedure
- preparation
- new amines
- amines
- new
- Prior art date
Links
- 150000001412 amines Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
- C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
- C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
- C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
- C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
- C07C217/34—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
Priority Applications (25)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE7204321A SE384853B (sv) | 1972-04-04 | 1972-04-04 | Forfarande for framstellning av nya aminer |
AR250907A AR204982A1 (es) | 1972-04-04 | 1973-01-01 | Procedimiento para preparar nuevos derivados de 1-fenoxi-2hidroxi-3-isopropilamina |
ZA732119A ZA732119B (en) | 1972-04-04 | 1973-03-27 | New amines and process for their preparation |
BE129334A BE797414A (fr) | 1972-04-04 | 1973-03-28 | Nouvelles amines et procede pour leur preparation |
FI1026/73A FI63741C (fi) | 1972-04-04 | 1973-04-03 | Analogifoerfarande foer framstaellning av nya substituerade feoxipropanolaminer med hjaertselektiv beta-receptor blocke rade verkan |
NL7304606A NL7304606A (de) | 1972-04-04 | 1973-04-03 | |
IE520/73A IE38302B1 (en) | 1972-04-04 | 1973-04-03 | Aromatic hydroxy amines |
GB1584673A GB1421824A (en) | 1972-04-04 | 1973-04-03 | Aromatic hydroxy amines |
SU1907907A SU533336A3 (ru) | 1972-04-04 | 1973-04-03 | Способ получени аминопропанолов,их солей или оптически-активных антиподов |
CA167,812A CA1017755A (en) | 1972-04-04 | 1973-04-03 | Amines and process for their preparation |
FR7312015A FR2179069B1 (de) | 1972-04-04 | 1973-04-03 | |
ES413316A ES413316A1 (es) | 1972-04-04 | 1973-04-03 | Un procedimiento para la preparacion de aminas. |
CH481673A CH587222A5 (de) | 1972-04-04 | 1973-04-04 | |
AT242774A AT321893B (de) | 1969-04-23 | 1973-04-04 | Verfahren zur herstellung von neuen substituierten 3-phenoxy-aminopropan-2-olen und deren säureaddiotionssalzen |
JP48037950A JPS5924971B2 (ja) | 1972-04-04 | 1973-04-04 | 新規なアミン類の製造方法 |
CH238076A CH587225A5 (de) | 1972-04-04 | 1973-04-04 | |
AT293873A AT321276B (de) | 1972-04-04 | 1973-04-04 | Verfahren zur Herstellung von neuen substituierten 3-Phenoxy-aminopropan-2-olen und deren Säureadditionssalzen |
US05/347,625 US3996382A (en) | 1972-04-04 | 1973-04-04 | Phenoxy-hydroxypropylamines, their preparation, and method and pharmaceutical preparations for treating cardiovascular diseases |
CH237976A CH587224A5 (de) | 1972-04-04 | 1973-04-04 | |
BR732430A BR7302430D0 (pt) | 1972-04-04 | 1973-04-04 | Processo para preparacao de novas aminas; novas aminas e cesso para tratar doencas cardio-vasculares ompostos correspondentes, preparacoes farmaceuticas e pro |
DE2316727A DE2316727C3 (de) | 1972-04-04 | 1973-04-04 | o,p-Disubstituierte 3-Phenoxy-lalkylamino-propan-2-ole, Verfahren zu deren Herstellung und sie enthaltende Arzneimittel |
NO1377/73A NO139167C (no) | 1972-04-04 | 1973-04-04 | Analogifremgangsmaate for fremstilling av nye terapeutisk aktive aminer |
ES439804A ES439804A1 (es) | 1972-04-04 | 1975-07-29 | Un procedimiento para la preparacion de aminas. |
ES439803A ES439803A1 (es) | 1972-04-04 | 1975-07-29 | Un procedimiento para la preparacion de aminas. |
US05/719,345 US4145442A (en) | 1972-04-04 | 1976-08-31 | Phenoxy-hydroxypropylamines, their preparation, and method and pharmaceutical preparations for treating cardiovascular diseases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE7204321A SE384853B (sv) | 1972-04-04 | 1972-04-04 | Forfarande for framstellning av nya aminer |
Publications (1)
Publication Number | Publication Date |
---|---|
SE384853B true SE384853B (sv) | 1976-05-24 |
Family
ID=20263926
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7204321A SE384853B (sv) | 1969-04-23 | 1972-04-04 | Forfarande for framstellning av nya aminer |
Country Status (19)
Country | Link |
---|---|
US (1) | US3996382A (de) |
JP (1) | JPS5924971B2 (de) |
AR (1) | AR204982A1 (de) |
AT (1) | AT321276B (de) |
BE (1) | BE797414A (de) |
BR (1) | BR7302430D0 (de) |
CA (1) | CA1017755A (de) |
CH (3) | CH587222A5 (de) |
DE (1) | DE2316727C3 (de) |
ES (3) | ES413316A1 (de) |
FI (1) | FI63741C (de) |
FR (1) | FR2179069B1 (de) |
GB (1) | GB1421824A (de) |
IE (1) | IE38302B1 (de) |
NL (1) | NL7304606A (de) |
NO (1) | NO139167C (de) |
SE (1) | SE384853B (de) |
SU (1) | SU533336A3 (de) |
ZA (1) | ZA732119B (de) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5001161A (en) * | 1984-01-10 | 1991-03-19 | Aktiebolaget Hassle | Pharmaceutical composition comprising metroprolol succinate |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU169464B (de) * | 1974-02-20 | 1976-11-28 | ||
IL48309A (en) * | 1974-10-25 | 1980-01-31 | Robins Co Inc A H | 1-aryloxy-4-amino-2-butanols and pharmaceutical compositions containing them |
JPS5337126A (en) * | 1976-09-17 | 1978-04-06 | Nishida Marine Boiler | Obtaining method of nickel from low grade nickel ore |
JPS55161036A (en) * | 1979-06-05 | 1980-12-15 | Ooeyama Nickel Kk | Nickel oxide ore smelting method |
ZW9881A1 (en) * | 1980-06-02 | 1981-12-23 | Hoffmann La Roche | Substituted phenoxyaminopropanol derivatives |
FR2497194B1 (fr) * | 1980-08-07 | 1985-06-14 | Sandoz Sa | Nouveaux composes phenoliques |
CH643527A5 (en) * | 1980-10-24 | 1984-06-15 | Ciba Geigy Ag | Process for the preparation of 1-alkylamino-3-(4-(2-lower alkoxy-ethyl)phenoxy)-2-propanols |
DE3125636A1 (de) * | 1981-06-30 | 1983-01-13 | Merck Patent Gmbh, 6100 Darmstadt | 1-(p-2-isopropoxyethoxymethyl-phenoxy)-3-isopropylamino-propan-2-ol zur senkung des augeninnendrucks und ophtalmikum, enthalten diese verbindung |
US5064827A (en) * | 1988-12-15 | 1991-11-12 | Du Pont Merck Pharmaceutical Company | Polyhydroxybenzyloxpropanolamines |
US4959390A (en) * | 1988-12-15 | 1990-09-25 | E. I. Du Pont De Nemours And Company | Polyhydroxybenzyloxypropanolamines |
KR100469946B1 (ko) * | 1998-04-14 | 2005-05-17 | 삼성정밀화학 주식회사 | 키랄(s)-2,3-치환-1-프로필아민유도체의제조방법 |
KR100489649B1 (ko) * | 1998-04-14 | 2005-09-02 | 삼성정밀화학 주식회사 | (s)-3-치환-2-히드록시프로필아민의제조방법 |
KR100469947B1 (ko) * | 1998-04-14 | 2005-04-08 | 삼성정밀화학 주식회사 | 키랄(s)-3-아미노-1,2-프로판디올의제조방법 |
US20010018446A1 (en) | 1999-09-23 | 2001-08-30 | G.D. Searle & Co. | Substituted N-Aliphatic-N-Aromatictertiary-Heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1220440B (de) * | 1962-02-14 | 1966-07-07 | Sanol Arznei Schwarz Gmbh | Verfahren zur Herstellung von Derivaten des 1-(o-Bromphenoxy)-2-hydroxy-3-amino-propans und deren Saeureadditionssalzen |
US3459782A (en) * | 1963-08-26 | 1969-08-05 | Boehringer Sohn Ingelheim | 1-substituted phenoxy-2-hydroxy-3-isopropylamino-propanes |
CH477400A (de) * | 1964-09-10 | 1969-10-15 | Ciba Geigy | Verfahren zur Herstellung neuer Amine |
NL6504268A (de) * | 1965-04-03 | 1966-10-04 | ||
FR1547605A (fr) * | 1967-09-27 | 1968-11-29 | Amp Inc | Connecteurs pour fusibles en cartouches |
CH512427A (de) * | 1967-12-18 | 1971-09-15 | Boehringer Sohn Ingelheim | Verfahren zur Herstellung von neuen racemischen oder optisch aktiven 1-Phenoxy-2-hydroxy-3-sec. -alkylaminopropanen |
US3740444A (en) * | 1968-01-25 | 1973-06-19 | Boehringer Sohn Ingelheim | Therapeutic compositions and method |
GB1285038A (en) * | 1969-02-21 | 1972-08-09 | Ici Ltd | Alkanolamine derivatives |
US3639634A (en) * | 1969-03-06 | 1972-02-01 | Dow Chemical Co | Cardiac antiarrhythmic method and composition employing alkylamino-alkoxyhalophenol compounds |
JPS4943947B1 (de) * | 1970-04-03 | 1974-11-25 | ||
SE372762B (de) * | 1969-05-21 | 1975-01-13 | Haessle Ab | |
SE354851B (de) * | 1970-02-18 | 1973-03-26 | Haessle Ab | |
JPS5146113B2 (de) * | 1972-09-01 | 1976-12-07 |
-
1972
- 1972-04-04 SE SE7204321A patent/SE384853B/xx unknown
-
1973
- 1973-01-01 AR AR250907A patent/AR204982A1/es active
- 1973-03-27 ZA ZA732119A patent/ZA732119B/xx unknown
- 1973-03-28 BE BE129334A patent/BE797414A/xx not_active IP Right Cessation
- 1973-04-03 SU SU1907907A patent/SU533336A3/ru active
- 1973-04-03 NL NL7304606A patent/NL7304606A/xx not_active Application Discontinuation
- 1973-04-03 FR FR7312015A patent/FR2179069B1/fr not_active Expired
- 1973-04-03 FI FI1026/73A patent/FI63741C/fi active
- 1973-04-03 IE IE520/73A patent/IE38302B1/xx unknown
- 1973-04-03 GB GB1584673A patent/GB1421824A/en not_active Expired
- 1973-04-03 CA CA167,812A patent/CA1017755A/en not_active Expired
- 1973-04-03 ES ES413316A patent/ES413316A1/es not_active Expired
- 1973-04-04 CH CH481673A patent/CH587222A5/xx not_active IP Right Cessation
- 1973-04-04 DE DE2316727A patent/DE2316727C3/de not_active Expired
- 1973-04-04 CH CH237976A patent/CH587224A5/xx not_active IP Right Cessation
- 1973-04-04 AT AT293873A patent/AT321276B/de active
- 1973-04-04 BR BR732430A patent/BR7302430D0/pt unknown
- 1973-04-04 JP JP48037950A patent/JPS5924971B2/ja not_active Expired
- 1973-04-04 NO NO1377/73A patent/NO139167C/no unknown
- 1973-04-04 CH CH238076A patent/CH587225A5/xx not_active IP Right Cessation
- 1973-04-04 US US05/347,625 patent/US3996382A/en not_active Expired - Lifetime
-
1975
- 1975-07-29 ES ES439803A patent/ES439803A1/es not_active Expired
- 1975-07-29 ES ES439804A patent/ES439804A1/es not_active Expired
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5001161A (en) * | 1984-01-10 | 1991-03-19 | Aktiebolaget Hassle | Pharmaceutical composition comprising metroprolol succinate |
Also Published As
Publication number | Publication date |
---|---|
NO139167B (no) | 1978-10-09 |
IE38302B1 (en) | 1978-02-15 |
ES439804A1 (es) | 1977-04-16 |
CH587224A5 (de) | 1977-04-29 |
ES413316A1 (es) | 1976-06-01 |
FR2179069B1 (de) | 1976-04-09 |
BR7302430D0 (pt) | 1974-02-07 |
DE2316727B2 (de) | 1978-06-22 |
AT321276B (de) | 1975-03-25 |
FR2179069A1 (de) | 1973-11-16 |
JPS5924971B2 (ja) | 1984-06-13 |
ES439803A1 (es) | 1977-04-16 |
US3996382A (en) | 1976-12-07 |
FI63741C (fi) | 1983-08-10 |
NL7304606A (de) | 1973-10-08 |
CH587225A5 (de) | 1977-04-29 |
DE2316727C3 (de) | 1979-02-22 |
AR204982A1 (es) | 1976-03-31 |
CA1017755A (en) | 1977-09-20 |
SU533336A3 (ru) | 1976-10-25 |
NO139167C (no) | 1979-01-17 |
JPS4913129A (de) | 1974-02-05 |
BE797414A (fr) | 1973-07-16 |
ZA732119B (en) | 1974-01-30 |
CH587222A5 (de) | 1977-04-29 |
DE2316727A1 (de) | 1974-01-10 |
GB1421824A (en) | 1976-01-21 |
IE38302L (en) | 1973-10-04 |
FI63741B (fi) | 1983-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE407579B (sv) | Forfarande for framstellning av n-fosfonometylglycin | |
SE382059B (sv) | Forfarande for framstellning av nya substituerade piperidinderivat | |
SE386445B (sv) | Forfaranden for framstellning av nya bensotiadiazoler | |
NO140731C (no) | Fremgangsmaate for fremstilling av dimetyleter | |
SE382060B (sv) | Forfarande for framstellning av nya substituerade piperidinoalkanonoximderivat | |
SE384853B (sv) | Forfarande for framstellning av nya aminer | |
SE422801B (sv) | Forfarande for framstellning av nya cefalosporinforeningar | |
SE395149B (sv) | Forfarande for framstellning av dibenso-tiepinylpiperazinderivat | |
SE420322B (sv) | Anvendning av nya gamma-glutamyl-4-nitroanild-derivat for bestemning av gamma-glutsmyltranspeptidas | |
SE401676B (sv) | Forfarande for framstellning av dibensofuranderivat | |
SE386892B (sv) | Forfarande for framstellning av oxaminoforeningar | |
SE382053B (sv) | Forfarande for framstellning av bifenylylalkanoylaminopyridiner | |
SE383151B (sv) | Forfarande for framstellning av 1-hydroxi-2-pyridoner | |
SE380272B (sv) | Forfarande for framstellning av n-fosfonmetylglycin | |
SE393111B (sv) | Forfarande for framstellning av d-2-halogen-6-metyl-8-substituerad - ergolin | |
SE397088B (sv) | Forfarande for framstellning av nya 2-propanolderivat | |
SE382980B (sv) | Forfarande for framstellning av nya derivat av hexahydrofenantridin | |
FI56830B (fi) | Foerfarande foer framstaellning av asparaginylgrupper innehaollande biologiskt aktiva polypeptider | |
SE393808B (sv) | Forfarande for framstellning av isomaltit | |
SE415355B (sv) | Forfarande for framstellning av fosfonotioureider | |
SE384510B (sv) | Forfarande for framstellning av nya isoindolinpiperazinderivat | |
SE384027B (sv) | Forfarande for framstellning av nya alfa-alkylsulfobensylpenicilliner | |
SE391717B (sv) | Forfarande for framstellning av 4-aryl-5-aminoalkyl-4-oxazolin-2-oner | |
NO136750C (no) | Fremgangsm}te for fremstilling av indanderivater | |
SE386681B (sv) | Forfarande for framstellning av nya cefalosporinderivat |